Alle Insider-Transaktionen auf den wichtigsten Aktienmärkten
| 30 Tage | Letzte 90 Tage | 120 Tage | |
|---|---|---|---|
| Durchschnittliche Rendite | 10% | 8.2% | 15.1% |
| Erfolgsquote | 87% | 68% | 82% |
| Transaktionen |
12
100% Kauf
|
34
71% Kauf
|
47
69% Kauf
|
| Position | Unternehmen | Zeitraum |
|---|---|---|
| Independent Chairman of the Board | BioXcel Therapeutics Inc | 1. April 2017 - |
| President of R&D and Chief Scientific Officer | Axcella Health Inc | None - |
| Executive Vice President - Global Research and Development, Chief Scientific Officer | Vertex Pharmaceuticals Inc | 15. Mai 2009 - 31. Oktober 2014 |